Patient disposition. (A) Disposition according to treatment received. (B) Disposition according to transplantation status: patients remaining alive for ≥2 years without relapse in the gilteritinib arm. (C) Disposition by preselected chemotherapy: patients remaining alive for ≥2 years without relapse in the gilteritinib arm. Due to limited follow-up of patients in the SC arm, data related to posttransplant relapse and survival were not available. ITT, intention-to-treat.